Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

Acyclovir - Generic Drug Details

« Back to Dashboard

What are the generic sources for acyclovir and what is the scope of acyclovir freedom to operate?

Acyclovir
is the generic ingredient in six branded drugs marketed by Watson Labs, Valeant Bermuda, Amneal Pharms, Actavis Elizabeth, Mylan Pharms Inc, Apotex Inc, Zydus Pharms Usa Inc, Teva Pharms, Hi Tech Pharma, Mylan, Teva, Dava Pharms Inc, Fougera Pharms Inc, Chartwell Molecules, Hetero Labs Ltd V, Ivax Sub Teva Pharms, Actavis Mid Atlantic, Cadila Pharms Ltd, Lek Pharm, Taro, Roxane, Ranbaxy, VIB, Sun Pharm Inds Ltd, Carlsbad, Heritage Pharms Inc, Stason, Cipher Pharms Us, Aurobindo Pharma Ltd, Glaxosmithkline, Eurohlth Intl Sarl, Abbvie, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Teva Parenteral, Hikma Pharms Llc, Athenex Inc, and Apothecon, and is included in sixty-four NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Acyclovir has thirty-two patent family members in twenty-four countries.

There are fifty-five drug master file entries for acyclovir. Sixty-four suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: acyclovir

Tradenames:6
Patents:7
Applicants:39
NDAs:64
Drug Master File Entries: see list55
Suppliers / Packagers: see list64
Bulk Api Vendors: see list112
Clinical Trials: see list21
Patent Applications: see list6,409
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:acyclovir at DailyMed

Tentative approvals for ACYCLOVIR

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe200MGCAPSULE;ORAL
► Subscribe► Subscribe800MGTABLET;ORAL
► Subscribe► Subscribe400MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Molecules
ACYCLOVIR
acyclovir
TABLET;ORAL074834-002Apr 24, 1997DISCNNoNo► Subscribe► Subscribe
Glaxosmithkline
ZOVIRAX
acyclovir sodium
INJECTABLE;INJECTION018603-003Aug 30, 1983DISCNYesNo► Subscribe► Subscribe
Teva
ACYCLOVIR
acyclovir
TABLET;ORAL074556-001Apr 22, 1997DISCNNoNo► Subscribe► Subscribe
Valeant Bermuda
XERESE
acyclovir; hydrocortisone
CREAM;TOPICAL022436-001Jul 31, 2009RXYesYesRE39264► SubscribeY ► Subscribe
Hetero Labs Ltd V
ACYCLOVIR
acyclovir
TABLET;ORAL203834-001Oct 29, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot